Elutia to Participate in Upcoming Investor Conferences

About this update from Elutia, Inc.

GAITHERSBURG, Md., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia”), a pioneer in drug-eluting biomatrix technologies, today announced that Dr. Randy Mills, President and Chief Executive Officer, and Matt Ferguson, Chief Financial Officer, will participate in the following upcoming investor conferences in New York: Cantor Global Healthcare Conference Format: Fireside Chat and 1x1 Meetings Fireside Chat Date and Time: Thursday, September 4, 2025, 9:45 a.m. ET Webcast Link: Click Here H.C. Wainwright 27th Annual Global Investment Conference Format: Presentation and 1x1 Meetings Presentation Date and Time: Wednesday, September 10, 2025, 9:30 a.m. ET Webcast Link: Click Here Lake Street Capital Markets 9th Annual Best Ideas Growth Conference Format: 1x1 Meetings Date: Thursday, September 11, 2025 Institutional investors interested in scheduling a meeting may contact their Cantor, H.C. Wainwright, or Lake Street representative or email [email protected] . About Elutia Elutia develops and commercializes drug-eluting biomatrix products to improve compatibility between medical devices and the patients who need them. With a growing population in need of implantable technologies, Elutia’s mission is humanizing medicine so patients can thrive without compromise. For more information, visit  www.Elutia.com . Investors: Matt Steinberg FINN Partners [email protected] This press release was published by a CLEAR® Verified individual.

View stock analysis, news, and events for Elutia, Inc.